This educational program consists of 4 videos on hypertrophic cardiomyopathy (HCM).
Epidemiology and clinical features of HCM – Perry Elliott, MD, PhD – London, UK
- Perry Elliott sets the stage for this series on HCM with data on the prevalence, differential diagnosis, and clinical presentations of the disease.
Evaluation of the complex cardiac pathophysiology in HCM – Ahmad Masri, MD – Portland, OR, US
- Join Ahmad Masri for a review of the pathophysiology of HCM and the evaluation of patients using peak VO₂ and cardiopulmonary exercise testing.
Myosin inhibitors: recent clinical data and applications in HCM and HF – Caroline Coats, MD – Glasgow, UK
- Tune in to hear Caroline Coats present an overview ofoutcomes of clinical trials with myosin inhibitors in HCM and ongoing/future trials in this field .
Recommendations on the management of HCM in guidelines: European vs. American views -Roberto Barriales-Villa, MD, PhD – A Coruña, Spain and Ahmad Masri, MD – Portland, OR, US New European and American guidelines on the management of cardiomyopathies have been released in 2023 and 2024. Here’s what you need to know.
Facebook Comments